RETA Short Information, Reata Pharmaceuticals Inc.
home / stock / reta / reta short
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 1,185,106 |
| Total Actual Volume | 9,467,309 |
| Short Trends | |
|---|---|
| Cover Days | 6 |
| Short Days | 9 |
| No Change Days | 5 |
| Averages | |
|---|---|
| Average Short Volume | 59,255 |
| Average Short Percentage | 47.15% |
Is there a RETA Short Squeeze or Breakout about to happen?
See the RETA Short Analysis for free Sign up or Login
Powered by Squeeze Report
RETA Twenty Trading Day's Volume to Short Volume Chart
RETA Twenty Trading Day Price Chart
RETA Short Data Results Days
| Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 2022-06-30 | 31.1 | 30.39 | 31.37 | 29.92 | 245,620 | 29,061 | 70.5895 |
| 2022-06-29 | 30.7 | 32.05 | 32.12 | 30.1484 | 319,720 | 27,462 | 26.6270 |
| 2022-06-28 | 32.7 | 30.54 | 32.77 | 30.36 | 314,603 | 19,331 | 35.0930 |
| 2022-06-27 | 31.36 | 32.92 | 33.3 | 30.81 | 365,071 | 50,857 | 39.4852 |
| 2022-06-24 | 33.79 | 31.08 | 34 | 30.85 | 505,633 | 19,579 | 26.0615 |
| 2022-06-23 | 32.33 | 33.3 | 33.62 | 31.815 | 397,957 | 22,245 | 20.2988 |
| 2022-06-22 | 32.17 | 32.36 | 34.4688 | 31.1512 | 531,762 | 73,062 | 54.5732 |
| 2022-06-21 | 31.26 | 32.52 | 32.65 | 31.231 | 442,268 | 26,749 | 32.0336 |
| 2022-06-16 | 30.4 | 30.93 | 31.12 | 29.58 | 517,189 | 40,442 | 38.6063 |
| 2022-06-15 | 29.2 | 31.24 | 31.26 | 28.58 | 698,467 | 85,107 | 38.1237 |
| 2022-06-14 | 30.92 | 28.97 | 30.92 | 28.9 | 440,195 | 34,262 | 28.4497 |
| 2022-06-13 | 31.66 | 30.96 | 32.13 | 28.9 | 441,375 | 86,012 | 71.7981 |
| 2022-06-09 | 34.4 | 34.61 | 34.88 | 33.32 | 246,867 | 30,008 | 63.9271 |
| 2022-06-08 | 34.17 | 34.76 | 36.31 | 34.17 | 243,540 | 32,582 | 55.9367 |
| 2022-06-06 | 31.76 | 32.16 | 32.7772 | 31.13 | 342,791 | 56,809 | 66.4814 |
| 2022-06-03 | 29.5 | 31.71 | 33.79 | 29.5 | 1,020,121 | 211,763 | 67.4882 |
| 2022-06-02 | 27.25 | 28.59 | 29 | 27.25 | 266,603 | 30,696 | 61.2976 |
| 2022-06-01 | 28.69 | 27.45 | 28.875 | 26.77 | 325,576 | 50,633 | 74.3510 |
| 2022-05-31 | 29.51 | 28.28 | 29.51 | 27.58 | 583,150 | 76,408 | 43.8308 |
| 2022-05-26 | 27.83 | 27.8 | 28.25 | 25.86 | 1,218,801 | 182,038 | 27.8566 |
Reata Pharmaceuticals Inc. Company Name:
RETA Stock Symbol:
NASDAQ Market:
Reata Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Friedreich’s Ataxia is a Rare, Progressive, Life-Shortening, Neuromuscular Disease that Affects Approximately 5,000 Patients in the United States Application Assigned a PDUFA Date of November 30, 2022 If Approved, Omaveloxolone Would Become the First A...
-
Completed Rolling Submission of NDA for Omaveloxolone for Treatment of Patients with Friedreich’s Ataxia; Actively Preparing for Commercial Launch Updates Outcome of Type A Meeting with the FDA on the Protocol Amendment for FALCON Reaffirms Cash Runway Through e...
-
Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announced that it will report financial results for the first quarter en...